The effects of aspirin on pro-inflammatory response in subjects with diabetes mellitus

Not Applicable

Completed

• Conditions: utritional, Metabolic, Endocrine: Diabetes; Nutritional, Metabolic, Endocrine; Diabetes

• Registration Number: ISRCTN45751416
• Lead Sponsor: Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09-12
• Last Update Posted: 3 July 2017

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

Not provided at time of registration

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in IL-6 release in response to aspirin.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration